- Home
- TIL vs SANG Comparison
TIL vs SANG Comparison
Compare TIL & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- SANG
- Stock Information
- Founded
- TIL 2018
- SANG 1984
- Country
- TIL United States
- SANG Canada
- Employees
- TIL N/A
- SANG N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- TIL Health Care
- SANG Technology
- Exchange
- TIL Nasdaq
- SANG Nasdaq
- Market Cap
- TIL 230.1M
- SANG 213.1M
- IPO Year
- TIL 2021
- SANG 2021
- Fundamental
- Price
- TIL $31.69
- SANG $5.67
- Analyst Decision
- TIL Buy
- SANG
- Analyst Count
- TIL 5
- SANG 0
- Target Price
- TIL $119.00
- SANG N/A
- AVG Volume (30 Days)
- TIL 263.6K
- SANG 2.6K
- Earning Date
- TIL 08-12-2025
- SANG 09-17-2025
- Dividend Yield
- TIL N/A
- SANG N/A
- EPS Growth
- TIL N/A
- SANG N/A
- EPS
- TIL N/A
- SANG N/A
- Revenue
- TIL N/A
- SANG $238,264,000.00
- Revenue This Year
- TIL N/A
- SANG N/A
- Revenue Next Year
- TIL N/A
- SANG $2.91
- P/E Ratio
- TIL N/A
- SANG N/A
- Revenue Growth
- TIL N/A
- SANG N/A
- 52 Week Low
- TIL $9.85
- SANG $4.08
- 52 Week High
- TIL $92.00
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- TIL 60.55
- SANG 42.93
- Support Level
- TIL $25.58
- SANG $5.70
- Resistance Level
- TIL $32.76
- SANG $5.99
- Average True Range (ATR)
- TIL 2.55
- SANG 0.10
- MACD
- TIL 0.75
- SANG -0.05
- Stochastic Oscillator
- TIL 89.55
- SANG 6.82
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.